Bayer's Trasylol Woes Trigger First Liability Suit
Boosting controversy over Bayer AG's Trasylol product, a federal lawsuit accuses the German drug giant of concealing the results of a study that showed the bleeding-reduction drug could cause kidney failure....To view the full article, register now.
Already a subscriber? Click here to view full article